ARU home page | ARU Profile | Addiction Primer | Biological Basis | Research Findings
University Courses | Opportunities | Research Reports | Feedback

From M.A. Bozarth (1994). Opiate reinforcement processes: Reassembling multiple mechanisms. Addiction, 89, 1425-1435. [Tables have been omitted from this electronic version.]

Opiate Reinforcement Processes: 
Reassembling Multiple Mechanisms

Michael A. Bozarth
Behavioral Neuroscience Program
Department of Psychology
State University of New York at Buffalo
Buffalo, New York 14260-4110 USA



Opiate reinforcement processes can be described within the context of operant conditioning theory. Both positive and negative reinforcing effects may motivate drug-taking behavior, although the strongest evidence attributes drug-taking to a simple positive reinforcement process. Empirical research has focused largely on a positive reinforcement mechanism involving the ventral tegmental dopamine system, but three additional reinforcement mechanisms can be argued on logical grounds. These other mechanisms involve neuroadaptive changes produced by chronic opiate administration and may contribute to the strong motivational impact of opiates following long-term drug use.


Considerable research during the past decade has emphasized a single appetitive motivational effect in the control of drug-taking behavior. Positive reinforcement from opiate or psychomotor stimulant activation of the ventral tegmental1 dopamine system accounts for a major portion of the reinforcement from these two pharmacological classes of drugs (see Bozarth, 1983, 1986, 1991; Wise & Bozarth, 1984, 1987). Other central nervous system (CNS) actions, such as opiate physical dependence, depend on activation of other brain systems not involved in the initial reinforcing action of these compounds (see Bozarth, 1983; Bozarth & Wise, 1983, 1984). Empirical work has focused largely on studying the positive reinforcing effect of acute opiate activation of the ventral tegmental dopamine system and has attempted to explore this action isolated from the numerous other opiate effects produced by systemic drug administration. Despite the use of intact animal preparations, this reinforcement process has been studied in relative isolation largely devoid of the confounding influence of other brain mechanisms.2 It is now time to reassemble the brain and to consider opiate action in the context of multiple effects on multiple brain systems.

This paper describes four putative motivational effects of opiates involving three motivational processes and two brain systems. Even so, this represents an over simplification of the complexity of opiate reward and its control of drug-taking behavior. Three of these components involve the ventral tegmental dopamine system and one involves the periventricular gray region.3 Two are positive reinforcement processes and two are negative reinforcement processes. Three of these actions are present only with chronic opiate administration.

Perspective for Studying Addiction

Several fundamental assumptions are adopted here for the study of opiate addiction. They involve the defining characteristics of drug addiction, the general approach to the study of behavior, and the dissociation of opiate effects. These assumptions are briefly outlined below.

Drug Addiction

Addiction is defined as a behavioral syndrome where drug procurement and administration appear to govern the organism's behavior (see Bozarth, 1990; Jaffe, 1975) and where the drug seems to dominate the organism's motivational hierarchy. With this definition physical dependence is neither a necessary nor defining characteristic of addiction. Furthermore, while this behavioral definition does not imply whether positive or negative reinforcement mechanisms are operative, it does permit a simple positive reinforcement mechanism as a sufficient determinant of addiction.

One feature of addiction that has received relatively little attention is motivational toxicity. As addiction develops, interest in other, natural reinforcers (e.g., food, sex) diminishes and behavior becomes more focused on drug procurement and administration. Concomitant with increased motivational strength for drug-related behaviors is a severe attenuation of the motivational properties of other reinforcers. The organism's motivational hierarchy is thus disrupted as addiction develops, and even behaviors essential for the survival and well-being of the organism have less motivational significance. This has been termed motivational toxicity (Wise & Bozarth, 1985), and it may be a defining characteristic of drug addiction (Bozarth, 1990).

The Behavioristic Approach

The American school of behaviorism has been a dominant force in experiment psychology. Behaviorism emphasizes observable events as determinants of behavior and de-emphasizes unobservable processes. This approach does not necessarily deny the involvement of cognitive processes in behavior, but rather it focuses on observable antecedent conditions as causes of observable behavioral responses. A direct outgrowth of behaviorism is operant conditioning theory, although behaviorism has spawned other explanations of behavior (e.g., classical conditioning theory). Operant conditioning theory may not provide an adequate description of motivated behavior (see Bindra, 1969; Bozarth, 1990, 1991), but it remains one of the most popular systems of analysis. With this caveat the neural mechanisms of opiate addiction are discussed within the constraints of this system of analysis.

Reinforcement Processes

Operant conditioning theory postulates three fundamental principles of behavior—positive reinforcement, negative reinforcement, and punishment. Positive reinforcement describes the situation where presentation of some stimulus event (e.g., food) increases the probability or frequency of the behavior it follows. Negative reinforcement describes the situation where the termination of some stimulus event (e.g., electric shock) increases the probability or frequency of the behavior its termination follows. Both positive and negative reinforcers increase behavioral responses; they differ in the temporal relationship between the behavior and the motivating stimulus—positive reinforcers follow the behavior they reinforce, while negative reinforcers precede the behavior they reinforce.4 (In colloquial terms, the organism is said to work to receive a positive reinforcer and to work to escape from or avoid a negative reinforcer.) Punishment is the third general principle of operant conditioning. Punishment describes the situation where presentation of an aversive stimulus following a behavior decreases the probability or frequency of that behavior. Unlike reinforcers, punishers suppress behavior. Radical behaviorism describes the effects of reinforcement and punishment on behavior devoid of their subjective impact (Skinner, 1953). Indeed, the emotional states associated with reinforcement and punishment are frequently viewed as the result of behavioral conditioning and not a cause of behavior. Other views suggest that the hedonic impact of reinforcing stimuli are inseparable from their reinforcing actions (Bindra, 1969) and that these affective consequences of a reinforcer provide their motivational effects (Young, 1959). Consistent with the tradition of operant conditioning theory, the present discussion will minimize reference to subjective states associated with reinforcement.

Drugs as Reinforcers

Drugs can be used as reinforcers in much the same manner as conventional reinforcers such as food and water. Similar patterns of responding are obtained using drug reinforcement in intravenous self-administration studies and in studies using conventional reinforcers (e.g., partial reinforcement and extinction effects; see Spealman & Goldberg, 1978). No special conditions (e.g., stress, food deprivation) are necessary for drugs to serve as reinforcers; only response contingent drug delivery in an operant conditioning paradigm is necessary to demonstrate the reinforcing effect of most addictive drugs. Experimental manipulations (e.g., Bozarth, Murray, & Wise, 1989) and preexisting organismic conditions (e.g., Piazza, Deminière, Maccari, Le Moal, Mormède, & Simon, 1991) may influence the initiation of drug self-administration, but these factors are not necessary conditions for drugs to serve as reinforcers in laboratory animals or in humans (see Bozarth, 1990).

Most drugs that are addictive in humans can serve as reinforcers in other mammals. This fact suggests that addictive drugs act on brain circuitry common to all mammals and that operant conditioning procedures can be used to study the biobehavioral basis of addiction using laboratory animal models (see Bozarth, 1987). Furthermore, a primary action of many addictive drugs seems to involve pharmacological activation of brain systems governing normal behavior. Indeed, addictive drugs can be used as tools to study some basic motivational processes and their underlying biological mechanisms.

Dissociation of Effects

Major advances in understanding drug addiction have been made by identifying and isolating the events necessary for drug reinforcement. Opiate administration can produce many effects including analgesia, changes in body temperature, cough suppression, mood elevation and euphoria, physical dependence, and narcosis. It is generally presumed that not all of these effects are necessary for the addictive properties of opiates, but identifying which of these seemingly ubiquitous actions are critical for addiction demands dissociation of these effects. This has been accomplished by studying these various actions in relative isolation—not confounded by other irrelevant effects. Research with laboratory animals has made a unique contribution to this goal.

A single example will be used to illustrate this principle. This example addresses the dissociation of opiate reinforcement from the physical dependence-producing effects of opiates. This issue is of primary interest in the study of addiction, because physical dependence has been offered as an explanation (even a defining characteristic) of drug addiction. Separation of physical dependence from reinforcement mechanisms demonstrates that drug-taking behavior can be established and maintained without the usual concomitant development of physical dependence and the potential negatively reinforcing effects of subsequent drug intake. This has contributed to a major conceptual advance concerning the nature of drug addiction.

The reinforcing effect of opiates has been temporally, procedurally, neuroanatomically, and neurochemically dissociated from their physical dependence-producing effects. Conditioning studies have shown that a single injection of opiate is rewarding (Bozarth & Wise, 1983). Thus, with no opportunity for relief of withdrawal discomfort from repeated injections, reinforcement and physical dependence mechanisms are temporally dissociated. Intravenous self-administration studies have used low-dose, limited access schedules of testing that apparently preclude the development of physical dependence (e.g., Dai, Corrigall, Coen, & Kalant, 1989; Ternes, Ehrman, & O'Brien, 1985). Thus, opiate reinforcement can be demonstrated at low exposure levels procedurally dissociating reinforcement and physical dependence mechanisms. Opiate infusions directly into the ventral tegmental area are reinforcing but fail to produce physical dependence (Bozarth & Wise, 1983, 1984); opiate infusions directly into the periventricular gray region are not reinforcing in drug-naive subjects but produce physical dependence. Thus, different CNS sites of action neuroanatomically dissociate reinforcement and physical dependence mechanisms. Finally, neuroleptics appear to block the initial reinforcing action of opiates (Bozarth & Wise, 1981a; Phillips, Spyraki, & Fibiger, 1982), but these dopamine-receptor blockers have little effect on the development of physical dependence. Thus, reinforcement and physical dependence can be dissociated by their underlying neurochemical mechanisms.

The study of reinforcement mechanisms demands the use of intact animal preparations. In vitro models can be used to study presumed correlates of drug reinforcement (e.g., opiate receptor binding, activation of second messengers), but only behaving organisms can truly assess reinforcing effects. Through the use of various experimental manipulations, relative isolation of reinforcement mechanisms has been achieved in situ, and the independent contributions of various brain systems have been studied in freely behaving animals with considerable success.

Opiate Reinforcement Mechanisms

Drug addiction is sometimes divided into two phases: acquisition and maintenance. This conceptual partitioning recognizes that different factors may be sequentially involved in the control of drug-taking behavior, although separate mechanisms have not been empirically demonstrated. This partitioning also reflects the increased motivational strength and motivational toxicity manifest as drug addiction develops.

Acute Reinforcing Effect and the Initiation of Drug-Taking Behavior

The acquisition of drug-taking behavior involves a positive reinforcement process. Without this action, reinforcement from opiate administration in drug-naive subjects would be dependent upon some interaction between a preexisting organismic condition and the drug effect (e.g., pain prior to analgesic drug administration). Because preexisting organismic conditions are not necessary for opiates to be reinforcing, positive reinforcement is presumed to mediate this initial rewarding action.5

The initial reinforcing effect of opiates involves activation of the ventral tegmental dopamine system. Opiate action at the ventral tegmentum is sufficient to produce reward (Bozarth & Wise, 1981b; Phillips & LePiane, 1980, van Ree & de Wied, 1980) and blocking opiate action in this brain region attenuates6 the reinforcing effect of systemically delivered opiate (Britt & Wise, 1983). Opiates have been shown behaviorally (Holmes, Bozarth, & Wise, 1983; Joyce & Iversen, 1979), electrophysiologically (Gysling & Wang, 1983; Matthews & German, 1984), and neurochemically (Di Chiara & Imperato, 1988; Westerink, 1978; Wood, 1983) to activate this dopamine system, and dopaminergic activity is essential for at least the initial rewarding effect of opiates (Bozarth & Wise, 1981a; Phillips et al., 1982). The most direct evidence of an essential role for the ventral tegmental dopamine system is the demonstration that destruction of the dopamine-containing cell bodies in the ventral tegmentum disrupts the acquisition of intravenous heroin self-administration (Bozarth & Wise, 1986).

These and numerous other studies argue for a critical role of the ventral tegmental dopamine system in the initial reinforcing action of opiates. This action involves an appetitive motivational process similarly activated by the psychomotor stimulants (Bozarth, 1986; Wise & Bozarth, 1987). Opiate activation of this system can also elicit other, natural behaviors such as feeding (Hamilton & Bozarth, 1988), maternal (Thompson & Kristal, 1992), and sexual (Mitchell & Stewart, 1990) behaviors. This system is where opiates interface with a brain mechanism mediating appetitive motivation and reward (Bozarth, 1991; Wise & Bozarth, 1987), and the contribution to addiction made by this system probably involves the pharmacological activation of neural mechanisms involved in the control of normal behavior (see Bozarth, 1990; Wise & Bozarth, 1987). But all of these studies involve the short-term effects of opiates and all fail to consider the long-term actions of repeated opiate administration.

Neuroadaptive Effects and the Maintenance of Drug-Taking Behavior

The repeated administration of opiates can produce neuroadaptive changes in CNS function that may give rise to additional motivational effects mediating continued opiate intake. These effects are absent during initial drug intake and therefore do not influence significantly the acquisition of drug-taking behavior. Nonetheless, these effects are potentially important components in the motivation to continue established drug-taking behavior and may be critical for developing the strong motivational properties characteristic of an addiction.

Negative Reinforcement from Relief of Withdrawal Distress

The most obvious mechanism for negative reinforcement involves the relief of withdrawal distress following repeated opiate administration. As physical dependence develops, subsequent opiate intake can relieve the discomfort associated with the opiate abstinence syndrome. This potential negative reinforcement mechanism may provide additional motivation to continue opiate self-administration. Considerable clinical research has addressed withdrawal reactions and their potential motivating effects, but little experimental attention has been directed toward studying this potential negative reinforcement mechanism in laboratory animals.

Some empirical support for a negative reinforcement mechanism related to opiate withdrawal has been obtained. Animals made physically dependent on opiates will lever press to avoid injections of a narcotic antagonist that precipitate withdrawal (Downs & Woods, 1973; Goldberg, Hoffmeister, Schlichting, & Wuttke, 1971). Animals develop conditioned place aversions to environmental stimuli associated with opiate withdrawal (Mucha, 1987). And narcotic antagonist microinjections into the periventricular gray region increase intravenous opiate self-administration (Corrigall & Vaccarino, 1988). These studies are consistent with the proposed motivational properties of withdrawal distress but do not demonstrate the importance of this mechanism in the control of drug-taking behavior.

Negative Reinforcement from Restoration of Normal Affective Tone

Another negative reinforcement process may evolve following repeated opiate intake. If the ventral tegmental dopamine system is involved in the regulation of normal affective tone and if chronic opiate intake decreases the level of tonic activity in this system, then subsequent opiate intake may help restore normal activity in a depressed ventral tegmental dopamine system. This would provide a second mechanism for negative reinforcement—one involving the same neural substrate as that mediating the positive reinforcing effect of opiates.

The ventral tegmental dopamine system is tonically active, and the activity of this system may help regulate normal affective tone. If depressed dopaminergic activity in this system produces anhedonia and depression, natural rewards could lose much of their motivational impact (see Wise, 1982). The impaired ability of natural rewards to activate this system might produce a negative contrast effect further disrupting the ability of nondrug reinforcers to influence behavior. This reward devaluation could cause increased motivational focusing toward drug reinforcement and might be a fundamental factor in motivational toxicity. A similar depression in dopaminergic activity has been suggested as a factor in cocaine addiction (Dackis & Gold, 1985).

Empirical support for this mechanism comes the demonstration that termination of repeated opiate administration decreases dopaminergic activity in this system (Pothos, Rada, Mark, & Hoebel, 1991; Rossetti, Hmaidan, & Gessa, 1992). A similar decrease in dopaminergic activity has been noted following the termination of cocaine administration (Bozarth, 1989; Rossetti et al., 1992). And normal dopaminergic activity is restored with continued opiate intake (Rossetti et al., 1992). Although these studies reveal a depression in dopamine function following repeated opiate administration, they do not test the motivational properties of this effect nor do they establish that similar depressions are seen with self-administered opiate. Possible negative reinforcement from restoration of normal dopamine function remains speculative. This potential mechanism is, however, consistent with the view that continued opiate intake is necessary for normal psychological functioning independent of the positive reinforcing action associated with euphoria and mood elevation.7

Enhanced Positive Reinforcement from Reward Sensitization

The defining characteristic of addiction is the strong motivational effect exerted by the addictive drug, and the hallmark of a positive contrast effect is the increased motivational impact of a positive reinforcer dependent on the abrupt increase in incentive value of the goal object.8 Opiates and psychomotor stimulants show increased stimulatory effects with repeated administration. Behavioral stimulation may involve the same neural substrate (i.e., the ventral tegmental dopamine system) as the positive reinforcing effect of these drugs (see Wise & Bozarth, 1987). And sensitization to the behavioral stimulant effect may reflect similar sensitization to the reinforcing effect of these compounds. Enhanced positive reinforcement may provide an intensified reinforcing impact following repeated drug use.9

Only limited data are available suggesting sensitization to the reinforcing effects of drugs.10 Pre-exposure to drug does seem to enhance the initial reinforcing impact of drug (e.g., Lett, 1989; Piazza, Deminière, Le Moal, & Simon, 1990). This is consistent with the proposed sensitization of a positive reinforcement mechanism, although other interpretations are equally viable. If opiates become increasingly effective in activating the ventral tegmental dopamine system with repeated use—and considerable data suggests that this system shows sensitization with both opiates and psychomotor stimulants—then the positive reinforcing impact of opiates would increase with chronic drug usage. This reward sensitization effect, along with a concomitant decrease in the ability of natural reinforcers to activate this system (i.e., devaluation of other motivational stimuli), would produce a particularly potent motivational effect.

Enhanced positive reinforcement from drug sensitization involves only a quantitative change in motivation but a qualitatively different mechanism physiologically.11 For this reason it might be considered an additional mechanism in the development of opiate addiction—one dependent on a neuroadaptive effect developing from repeated drug administration. But the basic motivational process remains positive reinforcement.

Integration of Motivational Processes

The initial rewarding effect of opiates involves a positive reinforcement process stimulated by opiate action in the ventral tegmentum, but chronic opiate reinforcement may recruit additional motivational processes both from a ventral tegmental action and from a periventricular gray action. These additional motivational processes involve neuroadaptive changes that may be critical for the full development of opiate addiction.

The motivational processes dependent on a ventral tegmental action are (i) positive reinforcement, (ii) enhanced positive reinforcement with a positive contrast effect, and (iii) negative reinforcement produced by normalization of depressed ventral tegmental dopamine function with the added feature of devalued competing reinforcers. The periventricular gray action involves a single negative reinforcement process related to the ability of opiates to relieve withdrawal distress. Hence, two negative reinforcement processes are involved—normalization of ventral tegmental dopamine function and relief of periventricular gray mediated withdrawal distress; two interdependent but temporally dissociable positive reinforcement processes are involved—activation of the physiologically normal ventral tegmental dopamine system and increased activation following sensitization to the drug action. This latter effect provides a mechanism for the enhanced motivational effect of opiates following chronic drug administration but still involving a positive reinforcement process.

The initial positive reinforcing impact of opiates involves an action shared with the psychomotor stimulants—activation of the ventral tegmental dopamine system. Continued drug intake probably produces neuroadaptive changes for both classes of drugs. Another action shared by these compounds may be depressed activity of this brain reward system when drug is absent and the subsequent negative reinforcement from continued drug intake. A mechanism not shared by these compounds involves the physical dependence syndrome produced by chronic opiate intake. The negative reinforcement obtained by the relief of opiate withdrawal discomfort may be unique to drugs that produce a clear physical dependence syndrome involving somatic disturbances.

The table summarizes four basic reinforcement mechanisms that may be operative during long-term opiate administration. Each of these mechanisms could contribute independently to drug-taking behavior, and some can be studied without the confounding influence of the other mechanisms. For example, positive reinforcement can be studied by limiting opiate action to the ventral tegmental area. And at least one negative reinforcement mechanism can be studied by restricting opiate action to the periventricular gray system. It is more difficult to dissociate the acute reinforcing and neuroadaptive effects within the ventral tegmental system. One approach might use low-dose, intermittent exposure to opiate in an attempt to minimize the development of neuroadaptive effects. Another approach would identify the molecular mechanisms mediating neuroadaptive responses and pharmacologically block these effects during chronic drug exposure. Such approaches to studying opiate reinforcement attempt to isolate individual reinforcement mechanisms to determine their separate contributions to drug-taking behavior.

Reassembling these multiple mechanisms is obviously important for considering the net reinforcing impact of opiates—these independent actions may combine in an additive fashion to produce the strong motivational impact characteristic of an addiction. What may not be so obvious is that other, derived processes may emerge from these primary motivational effects. Enhanced drug activation of this positive reinforcement substrate (i.e., sensitization of this reinforcement substrate to pharmacological activation) in a background of devalued conventional reinforcement (i.e., impaired ability of natural reinforcers to activate this system following physiologically depressed activity of this reinforcement substrate) may produce motivational toxicity and a type of motivational focusing unique to drug reinforcement. This characteristic may be the most salient feature of drug addiction and may involve an interactive effect of multiple reinforcement mechanisms. Without studying this and other derived processes, only mechanisms mediating the early stage of addiction can be addressed. A complete understanding of addiction thus necessitates reassembling multiple mechanisms to consider their interactive effects.


1. The term mesolimbic dopamine system might be used. The effects described as dependent on the ventral tegmental dopamine system probably involve dopamine action in the nucleus accumbens terminal field of this system, but other terminal projections (e.g., frontal cortex, central amygdaloid nucleus) of the A10 dopamine-containing cells might also be involved. Therefore, the term ventral tegmental dopamine system is used, although most empirical data specifically identify the mesolimbic system as critical from these effects.

2. In the author's research, this has been accomplished in two ways—by using central opiate administration that limits drug action to relatively discrete brain regions and by studying short-term, low-dose opiate reward that presumably minimizes the development of neuroadaptive changes.

3. Withdrawal discomfort following abrupt termination of physical dependence-producing opiate injections may contribute to drug-taking behavior. Several brain regions are undoubtedly involved in physical dependence (e.g., Bozarth, 1994, Wei, Loh, & Way, 1973), but for simplicity only the periventricular gray region is considered here.

4. Technically, reinforcement always follows the behavior it reinforces. Presentation of a positive reinforcer clearly follows the behavior it reinforcers, while presentation of a negatively reinforcing stimulus precedes the behavior it reinforcers. But in the latter case, the reinforcing event is considered the removable of the motivating stimulus. With this interpretation, reinforcement follows the behavior it strengthens regardless of whether the reinforcing stimulus is functioning as a positive or negative reinforcer. Rather than become overly involved with the semantics of operant conditioning theory, it is far simpler to consider the negative reinforcer as the motivating stimulus that precedes the reinforced behavior even though the reinforcing event is termination of that stimulus.

5. One might argue that extrinsic motivators mediate initial drug-taking behavior. Indeed, some factor such as peer pressure or curiosity is necessary to explain the first occurrence of drug self-administration. But these extrinsic factors are totally inadequate explanations of the potent motivation characteristic of even the acquisition phase of drug addiction as drug use escalates with increasing cost to the individual.

6. Blocking opiate action in the ventral tegmentum increases intravenous heroin self-administration; this effect has been interpreted as decreasing the effectiveness of intravenously delivered heroin (viz., the effect parallels the effect of decreasing the heroin dose delivered with each intravenous infusion). Although this does indeed suggest that opiate action in the ventral tegmentum is important for the rewarding impact of systemically delivered drug, it is important to note that central narcotic antagonist injections fail to totally block opiate self-administration. These studies have been performed in subjects trained to self-administer opiate and these data suggest that other mechanisms are involved in the regulation of opiate intake during chronic administration.

7. This is the often cited rationale of methadone and heroin maintenance programs—continued opiate intake is necessary to maintain normal psychological functioning, even when overt signs of opiate use are absent.

8. Positive contrast effects are produced by an abrupt increase in the magnitude of a positive reinforcer (e.g., increasing the number of food pellets obtained by performing the operant response). Behavioral contrast effects are usually short lived; with repeated trials, the performance level adjusts to the new incentive value of the reinforcer. The mechanism proposed here requires maintenance of this behavioral contrast effect despite continued exposure to the reinforcer. One mechanism might involve continued sensitization to reward with repeated drug administration (see Lett, 1989).

9. Robinson and Berridge (1993) have recently suggested a theory of addiction focusing on sensitization of this dopamine system. Lett (1989) has also proposed sensitization as a major determinant of drug addiction.

10. Stress also activates the ventral tegmental dopamine system, and enhanced drug reinforcement following stress could involve cross sensitization of a positive reinforcement mechanism (see Piazza et al., 1990).

11. Different CNS sites may be involved in sensitization and activation of the ventral tegmental dopamine system (see Kalivas & Stewart, 1991). For example, amphetamine sensitization develops from an action in the cell-body region (i.e., ventral tegmentum), while the dopamine-enhancing effect results from an action in the synaptic terminal field (i.e., nucleus accumbens). Also, some neurochemical events necessary for sensitization are probably not involved in the primary pharmacological actions of these drugs; it may be possible to block sensitization by neurochemical manipulations that do not affect the primary positive reinforcement mechanism. An indirect test of this hypothesis comes from the recent demonstration that blocking a neurochemical system involved in cocaine sensitization (Pudiak & Bozarth, 1993) does not affect cocaine's facilitation of brain stimulation reward (Bozarth, Pudiak, & Morris, 1994).

Selected Bibliography

Bindra, D. (1969). A unified interpretation of emotion and motivation. Annals of the New York Academy of Sciences 159: 1071-1083.

Bozarth, M.A. (1983). Opiate reward mechanisms mapped by intracranial self-administration. In J.E. Smith and J.D. Lane (eds.), Neurobiology of Opiate Reward Processes (pp. 331-339). Amsterdam: Elsevier/North Holland Biomedical Press.

Bozarth, M.A. (1986). Neural basis of psychomotor stimulant and opiate reward: Evidence suggesting the involvement of a common dopaminergic system Behavioral Brain Research 22: 107-116.

Bozarth, M.A. (1987). (ed.) Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag.

Bozarth, M.A. (1989). New perspectives on cocaine addiction: Recent findings from animal research. Canadian Journal of Physiology and Pharmacology 67: 1158-1167.

Bozarth, M.A. (1990). Drug addiction as a psychobiological process. In D.M. Warburton (ed.), Addiction Controversies (pp. 112-134). London: Harwood Academic Publishers.

Bozarth, M.A. (1991). The mesolimbic dopamine system as a model reward system. In P. Willner and J. Scheel-Krüger (eds.), The Mesolimbic Dopamine System: From Motivation to Action (pp. 301-330). London: John Wiley & Sons.

Bozarth, M.A. (1994). Physical dependence produced by central morphine infusions: A neuroanatomical mapping study. Neuroscience & Biobehavioral Reviews, in press.

Bozarth, M.A., Murray, A., & Wise, R.A. (1989). Influence of housing conditions on the acquisition of intravenous heroin and cocaine self-administration in rats. Pharmacology Biochemistry & Behavior 33: 903-907.

Bozarth, M.A., Pudiak, C.M., & Morris, M. (1994). Nitric oxide synthesis inhibition does not affect brain stimulation reward. Pharmacology Biochemistry & Behavior, in press.

Bozarth, M.A., & Wise, R.A. (1981a). Heroin reward is dependent on a dopaminergic substrate. Life Sciences 29: 1881-1886.

Bozarth, M.A., & Wise, R.A. (1981b). Intracranial self-administration of morphine into the ventral tegmental area. Life Sciences 28: 551-555.

Bozarth, M.A., & Wise, R.A. (1983). Dissociation of the rewarding and physical dependence-producing properties of morphine. In L.S. Harris (ed.), Problems of drug dependence, 1982 (National Institute on Drug Abuse Research Monograph 43, pp. 171-177). Washington, DC: U.S. Government Printing Office.

Bozarth, M.A., & Wise, R.A. (1984). Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 244: 516-517.

Bozarth, M.A., & Wise, R.A. (1986). Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. In L.S. Harris (ed.), Problems of Drug Dependence, 1985 (National Institute on Drug Abuse Research Monograph 67, pp. 190-196). Washington, DC: U.S. Government Printing Office.

Britt, M.D., & Wise, R.A. (1983). Ventral tegmental site of opiate reward: Antagonism by a hydrophilic opiate receptor blocker. Brain Research 258: 105-108.

Corrigall, W.A., & Vaccarino, F.J. (1988). Antagonist treatment in nucleus accumbens or periaqueductal grey affects heron self-administration. Pharmacology Biochemistry & Behavior 30: 443-450.

Dackis, C.A., & Gold, M.S. (1985). New concepts in cocaine addiction: The dopamine depletion hypothesis. Neuroscience & Biobehavioral Reviews 9: 469-477.

Dai, S., Corrigall, W.A., Coen, K.M., & Kalant, H. (1989). Heroin self-administration by rats: Influence of dose and physical dependence. Pharmacology Biochemistry & Behavior 32: 1009-1015.

Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Science U.S.A. 85: 5274-5278.

Downs, D.A., & Woods, J.H. (1973). Naloxone: Behavioral paradigms of aversive control. Pharmacologist 15: 236.

Goldberg, S.R., Hoffmeister, F., Schlichting, U., & Wuttke, W. (1971). Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 179: 268-276.

Gysling, K., & Wang, R.Y. (1983). Morphine-induced activation of A10 dopamine neurons in the rat. Brain Research 277: 119-127.

Hamilton, M.E., & Bozarth, M.A. (1988). Feeding elicited by dynorphin(1-13) microinjections into the ventral tegmental area in rats. Life Sciences 43: 941-946.

Holmes, L.J., Bozarth, M.A., & Wise, R.A. (1983). Circling from intracranial morphine applied to the ventral tegmental area in rats. Brain Research Bulletin 11: 295-298.

Jaffe, J.H. (1975). Drug addiction and drug abuse. In L.S. Goodman and A. Gilman (eds.), The Pharmacological Basis of Therapeutics (pp. 245-283). New York: MacMillan.

Joyce, E.M., & Iversen, S.D. (1979). The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neuroscience Letters 14: 207-212.

Kalivas, P.W., & Stewart, J. (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Research Reviews 16: 223-244.

Lett, B.T. (1989). Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology 98: 357-362.

Matthews, R.T., & German, D.C. (1984). Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11: 617-625.

Mitchell, J.B., & Stewart, J. (1990). Facilitation of sexual behaviors in the male rat associated with intra-VTA injections of opiates. Pharmacology Biochemistry & Behavior 33: 643-650.

Mucha, R.F. (1987). Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Research 418: 214-220.

Phillips, A.G., & LePiane, F.G. (1980). Reinforcing effects of morphine microinjections into the ventral tegmental area. Pharmacology Biochemistry & Behavior 12: 965-968.

Phillips, A.G., Spyraki, C., & Fibiger, H.C. (1982). Conditioned place-preference with amphetamine and opiates as reward stimuli: Attenuation by haloperidol. In B.G. Hoebel and D. Novin (eds.), The Neural Basis of Feeding and Reward (pp. 455-464). Brunswich, ME: Haer Institute.

Piazza, P.V., Deminière, J.-M., Maccari, S., Le Moal, M., Mormède, P., & Simon, H. (1991). Individual vulnerability to drug self-administration: Action of corticosterone on dopaminergic systems as a possible pathophysiological mechanisms. In P. Willner and J. Scheel-Krüger (eds.), The Mesolimbic Dopamine System: From Motivation to Action (pp. 473-495). London: John Wiley & Sons.

Piazza, P.V., Deminière, J.-M., Le Moal, M., & Simon, H. (1990). Stress- and pharmacological induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Research 514: 22-26.

Pothos, E., Rada, P., Mark, G.P., & Hoebel, B.G. (1991). Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Research 566: 348-350.

Pudiak, C.M., & Bozarth, M.A. (1993). L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sciences 55: 1517-1524.

Robinson, T.E., & Berridge, K.C. (1993). The Neural Basis of Drug Craving—An Incentive Sensitization Theory of Addiction. Brain Research Reviews 18: 247291.

Rossetti, Z.L., Hmaidan, Y., & Gessa, G.L. (1992). Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. European Journal of Pharmacology 221: 227-234.

Skinner, B.F. (1953). Science and Human Behavior. New York: MacMillan.

Spealman, R.D., & Goldberg, S.R. (1978). Drug self-administration by laboratory animals: Control by schedules of reinforcement. Annual Review of Pharmacology & Toxicology 18: 313-339.

Ternes, J.W., Ehrman, R.N., & O'Brien, C.P. (1985). Nondependent monkeys self-administer hydromorphone. Behavioral Neuroscience 99: 583-588.

Thompson, A.C., & Kristal, M.B. (1992). Opioids in the ventral tegmental area facilitate the onset of maternal behavior in the rat. Society for Neuroscience Abstracts 18: 659.

van Ree, J.M., & de Wied, D. (1980). Involvement of neurohypophyseal peptides in drug-mediated adaptive responses. Pharmacology Biochemistry & Behavior 13(Suppl. 1): 257-263.

Wei, E., Loh, H.H., & Way, E.L. (1973). Brain sites of precipitated abstinence in morphine-dependent rats. Journal of Pharmacology and Experimental Therapeutics 185: 108-115.

Westerink, B.H.C. (1978). Effect of centrally acting drugs on regional dopamine metabolism. In P.J. Roberts, G.N. Woodruff, and L.L. Iversen (eds.), Advances in Biochemical Psychopharmacology (pp. 255-266). New York: Raven Press.

Wise, R.A. (1982). Neuroleptics and operant behavior: The anhedonia hypothesis. Behavioral Brain Sciences 5: 39-87.

Wise, R.A., & Bozarth, M.A. (1984). Brain reward circuitry: Four circuit elements "wired" in apparent series. Brain Research Bulletin 297: 265-273.

Wise, R.A., & Bozarth, M.A. (1985). Interaction of drugs of abuse with brain mechanisms of reward. In L. Blum and L. Manzo (eds.), Neurotoxicology (pp. 111-133). New York: Marcel Dekker.

Wise, R.A., & Bozarth, M.A. (1987). A Psychomotor stimulant theory of addiction. Psychological Review 94: 469-492.

Wood, P.L. (1983). Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations, and species differences. Peptides 4: 595-601.

Young, P.T. (1959). The role of affective processes in learning and motivation. Psychological Review 66: 104-125.

©1994 Society for the Study of Addiction to Alcohol and Other Drugs

ARU home page | ARU Profile | Addiction Primer | Biological Basis | Research Findings
University Courses | Opportunities | Research Reports | Feedback